Please login to the form below

Not currently logged in
Email:
Password:

Activartis

This page shows the latest Activartis news and features for those working in and with pharma, biotech and healthcare.

FDA grants orphan status to Activartis’ brain cancer immunotherapy

FDA grants orphan status to Activartis’ brain cancer immunotherapy

Activartis' AV0113 is part of this growing trend, and the drug has shown promise in early-stage trials. ... time. According to Activartis, preliminary results revealed a “very promising trend” towards overall survival benefit in patients taking AV0113

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics